title: [Complementary treatment of acute heart failure in patients with diabetes, chronic obstructive pulmonary disease or anemia].
abstract: Diabetes, chronic obstructive pulmonary disease (COPD) and anemia are comorbidities with a high prevalence and impact in heart failure (HF). The presence of these comorbidities considerably worsens the prognosis of HF. Diabetic patients have a higher likelihood of developing symptoms of HF and both the treatment of diabetes and that of acute HF are altered by the coexistence of both entities. The glycemic targets in patients with acute HF are not well-defined, but could show a U-shaped relationship. Stress hyperglycemia in non-diabetic patients with HF could also have a deleterious effect on the medium-term prognosis. The inter-relationship between COPD and HF hampers diagnosis due to the overlap between the symptoms and signs of both entities and complementary investigations. The treatment of acute HF is also altered by the presence of COPD. Anemia is highly prevalent and is often the direct cause of decompensated HF, the most common cause being iron deficiency anemia. Iron replacement therapy, specifically intravenous forms, has helped to improve the prognosis of acute HF.
authors.affiliation: UGC Medicina Interna, Hospital Juan Ramón Jiménez, Complejo Hospitalario de Huelva, Huelva, España. Electronic address: fjcarrascos@telefonica.net.
authors.forename: Francisco Javier
authors.initials: FJ
authors.lastname: Carrasco Sánchez
authors.affiliation: Servicio de Medicina Interna, Hospital Vall d'Hebron, Barcelona, España.
authors.forename: Jesús
authors.initials: J
authors.lastname: Recio Iglesias
authors.affiliation: Servicio de Medicina Interna, Hospital Municipal de Badalona, Badalona, Barcelona, España.
authors.forename: Jordi
authors.initials: J
authors.lastname: Grau Amorós
mesh_terms: D000208:Acute Disease; D018798:Anemia, Iron-Deficiency / Q000150:complications / Q000188:drug therapy; D059347:Cardio-Renal Syndrome / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D002317:Cardiovascular Agents / Q000627:therapeutic use; D015897:Comorbidity; D048909:Diabetes Complications; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000097:blood / Q000150:complications / Q000628:therapy*; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy / Q000209:etiology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007501:Iron / Q000627:therapeutic use; D063087:Noninvasive Ventilation; D010102:Oxygen Inhalation Therapy; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000628:therapy
chemical_list: D002317:Cardiovascular Agents; D004232:Diuretics; D007004:Hypoglycemic Agents; D007501:Iron
keywords: Acute heart failure; Anemia; COPD; Diabetes; EPOC; Insuficiencia cardíaca aguda; Tratamiento; Treatment